Physician
Hematology
Dr. Francois J. Geoffroy, MD
|
|
Give Review
Francois J. Geoffroy, MD is an expert in the field of Hematology. He attended Tufts University School of Medicine. Tufts University School of Medicine has a rank of 49 in research and a 52 in primary care He has 1 awards "CMS Meaningful Use Stage 1 Certification". Francois Geoffroy is a published physician. He has 25 publications published. The most current publication "Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples." Francois J. Geoffroy is registered with Medicare and accepts Medicare payments.
Publications
- Isolated CNS Hodgkin's Lymphoma: implications for tissue diagnosis.
- A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Ce...
- Topotecan and paclitaxel in previously treated patients with relapsed small cell lung Cancer: phase II trial of the North Central Cancer Treatment Group.
- Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung Cancer.
- Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central Cancer treatment group study.
- Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group...
- Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon Cancer cells.
- Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung Cancer.
- A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal Cell carcinoma.
- Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast Cancer cells.
- Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification.
- Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples.
- Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
- High affinity human antibodies by phage display.
- Full-scale 'naïve' human antibody repertoires assembled from VH and VL variable regions.
- Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon Cancer cells.
- Murine cytomegalovirus inactivated by sodium periodate is innocuous and immunogenic in mice and protects them against death and infection.
- Inactivation of human cytomegalovirus by sodium periodate oxidation.
- Determinants of trimetrexate lethality in human colon Cancer cells.
- A new phage display System to construct multicombinatorial libraries of very large antibody repertoires.
- Chemotherapy of advanced gastrointestinal Cancer.
- Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma Cells.
- Cytotoxicity and metabolism of 4-methoxy-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon Cancer cells.
Schools
Tufts University School Of Medicine
St Vincent Hospital
Nih Nci
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Tufts University School of Medicine
Drug Facts
| NPI NUMBER | 1871593434 | |
| NPPES Provider LastName | GEOFFROY | |
| NPPES Provider FirstName | FRANCOIS | |
| NPPES Provider ZIPCode | 616157822 | |
| NPPES Provider State | IL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1065.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 67.0 | |
| Percent Opioid Claims | 6.29 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871593434 |
| Last Name Of The Provider | GEOFFROY |
| First Name Of The Provider | FRANCOIS |
| View All |
Similar Doctors
|
|
Dr. Paul A. Fishkin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Veeder, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Diane J. Prager, MD
This Doctor is OpenDoctor Recommended.
|